Susannah Gray
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Susannah Gray
Susannah Gray is recorded as CFO at Theravance Biopharma, Inc. (TBPH). Theravance Biopharma, Inc. reported in an 8-K filed September 23, 2026 that Susannah Gray resigned as Board of Directors, effective September 23, 2026. Theravance Biopharma, Inc. reported in an 8-K filed February 27, 2023 that Susannah Gray was appointed Class II member of the Board of Directors, effective February 26, 2023.
“at the Effective Time, each of Rick E Winningham, Laurie Smaldone Alsup, Susannah Gray, Dean J. Mitchell, Donal O’Connor and Deepa R. Pakianathan resigned from the Company’s Board of Directors”
“On February 26, 2023, Susannah Gray was appointed by the Board of Directors of Theravance Biopharma, Inc. (the "Company") to serve as a Class II member of the Board of Directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2026-09-23
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Theravance Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Dean J. Mitchell CEO
- Deepika R. Pakianathan CEO
- Laurie Smaldone Alsup CEO
- Rick Winningham CEO, Board Member
- Donal O’Connor Chairman
- Aziz Sawaf CFO
- Brett A. Grimaud General Counsel
- Deepika R. Pakianathan, Ph.D. Board Member
- James C. Kelly Board Member
- Jeremy Grant Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.